Updated August 5, 2008
Regado Biosciences names CEO, replacing VC who was co-founder
Durham, N.C. —Veteran pharmaceutical executive David Mazzo joins drug startup. Aurora Funds’ Douglas Gooding, who had led Durham-based startup., remains a consultant....Copyright 2013 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Please log in to view WRALTechWire Insider content
Please Log In to add a comment.